Author

Ruiying Wang

University of Massachusetts Chan Medical SchoolORCID 0000-0002-3638-4582Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Charles A. SpechtiD· 2 shared Diana Carlson· 2 shared Lorena V. N. OliveiraiD· 2 shared Maureen M. HesteriD· 2 shared Stuart M. LevitziD· 2 shared Camaron R. HoleiD· 1 shared Christina Gomez· 1 shared Chrono K. Lee· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Charles A. SpechtORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Immunological correlates of protection mediated by a whole organism Cryptococcus neoformans vaccine deficient in chitosan

Charles A. Specht, Ruiying Wang, Lorena V. N. Oliveira, Maureen M. Hester, Christina Gomez, Zhongming Mou, Diana Carlson, Chrono K. Lee, Camaron R. Hole, Woei C. Lam, Rajendra Upadhya, Jennifer K. Lodge, Stuart M. Levitz

This paper identifies CD4+ T cells and their cytokines IFNγ, TNF, and IL-23 as critical for vaccine-mediated protection against Cryptococcus neoformans, with protection retained after vaccination even with CD4+ T cell depletion.

mBio · Jul 9, 2024Peer-reviewedImmunology

Protection against experimental cryptococcosis elicited by Cationic Adjuvant Formulation 01-adjuvanted subunit vaccines

Ruiying Wang, Lorena V. N. Oliveira, Maureen M. Hester, Diana Carlson, Dennis Christensen, Charles A. Specht, Stuart M. Levitz

This paper develops multivalent cryptococcal vaccines using CAF01 adjuvant that protect mice from experimental cryptococcosis by inducing IFNγ and IL-17 responses.

PLoS Pathogens · Jul 8, 2024Peer-reviewedImmunology